6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Latest Press Releases

Time	Headline
17m ago	Sunrun Prices $584 million Securitization of Residential Solar and Storage Assets
17m ago	Madison Air Schedules First Quarter 2026 Earnings Conference Call and Webcast
41m ago	Ultra Clean Announces Retirement of the Chief Financial Officer Sheri Savage
41m ago	GridAI Technologies Corp. Announces Receipt of NASDAQ Notice Regarding Late Form 10-K Filing
41m ago	Rush Enterprises, Inc. Reports First Quarter 2026 Results, Announces $0.19 Per Share Dividend

About

Fennec Pharmaceuticals Inc (NASDAQ:FENC) — investor relations, events, news, and company updates on 6ix.

Latest News

Fennec Pharmaceuticals Announces Acceptance of Abstracts at the 2026 ASCO Annual Meeting

Fennec Pharmaceuticals Announces Investigator-Sponsored Study to Be Conducted by University of Arizona Cancer Center

Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Fennec Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2025 Financial Results on March 24, 2026

Financials

Revenue

$44.64 M

Market Cap

$221.33 M

EPS

-0.34

Community Chat

Ask AI